ABBV Stock Analysis: Buy, Sell, or Hold?
ABBV - ABBVIE INC.
$209.46
-5.52 (-2.57%)
▼
5d:
-0.79%
30d:
-11.32%
90d:
-8.33%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: Apr 24, 2026
21d
Smart Money Accumulation
ABBV is down 3.7% this week, but smart money is accumulating calls. Top strike: $250 2026-03-20 with 7,487 OI. Call ratio: 60% View Scanner →
Strength: 2.9/10
Get Alerted When ABBV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ABBV shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: ABBV shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$341.18
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$211.85
1.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ABBV is currently trading at $209.46, which is considered slightly low relative to its 30-day fair value range of $210.22 to $230.53. The stock's valuation (Forward PE: 13.3) is in line with its historical norms (14.8). Remarkably, the market is currently pricing in an annual earnings decline of 3.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ABBV is in a strong uptrend. Immediate support is located at $201.80, while resistance sits at $220.45.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $249.14 (+15.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ABBV is in a strong uptrend. Immediate support is located at $201.80, while resistance sits at $220.45.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $249.14 (+15.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$210.22 -
$230.53
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($249.14)
Fair Price Analysis
30-Day Fair Range
$210.22 -
$230.53
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$201.80
Resistance Level
$220.45
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.34
Wall Street Target
$249.14
(+15.9%)
Revenue Growth (YoY)
10.0%
Earnings Growth (YoY)
-88.7%
Profit Margin
6.9%
Valuation Discount vs History
-3.5% cheaper
PE vs Historical
13.3 vs 14.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.5%
(market-implied from PE analysis)
1-Year Target
$207.46
(-4%)
2-Year Target
$200.19
(-7%)
3-Year Target
$193.19
(-10%)
3-Yr Target (if PE normalizes)
(PE: 13→15)
$214.34
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 10.9%)
$490.82
(+128%)
Base:
(SPY PE: 13.3, Growth: 10.9%)
$292.95
(+36%)
Bear:
(PE: 11.3, Growth: 10.9%)
$249.01
(+16%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (14x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Forward PE: 14.08 | Forward EPS (Implied): $14.55
Bull Case
$247.45
(+21%)
Analyst growth 15.0%, PE expands to 14.8
Base Case
$204.93
(0%)
Market implied 0.0%, PE stable at 14.1
Bear Case
$156.77
(-24%)
Severe decline -15.0%, PE contracts to 12.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.3 to 14.8
Stabilization Target:
$238.52
(+10.9%)
PE Expansion Potential:
+10.9%
Share & Embed Analysis
Last updated: April 02, 2026 12:36 PM ET
Data refreshes hourly during market hours. Next update: 1:36 PM
Data refreshes hourly during market hours. Next update: 1:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABBV showing a specific setup today?
Insider Activity (6 Months)
3
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
David Ryan Purdue
SELL
5230 shares
2026-03-04
Perry C Siatis
SELL
22381 shares
2026-02-25
Ro Khanna
BUY
2026-02-05
Featured in Portfolios
ABBV is a key holding in these high-performance investment strategies.
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1209 | 58 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$157 | 54 HOLD |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$351 | 61 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$206 | 57 HOLD |
|
MRK
Merck & Company Inc |
BUY
26 analysts |
$128 | 59 HOLD |
Advanced ABBV Option Strategies
Professional options setups generated by AI based on today's ABBV price and gamma walls.
